Tao Su

15.4k total citations
125 papers, 3.6k citations indexed

About

Tao Su is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Tao Su has authored 125 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 17 papers in Surgery and 17 papers in Oncology. Recurrent topics in Tao Su's work include Traditional Chinese Medicine Analysis (11 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Natural product bioactivities and synthesis (10 papers). Tao Su is often cited by papers focused on Traditional Chinese Medicine Analysis (11 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Natural product bioactivities and synthesis (10 papers). Tao Su collaborates with scholars based in China, Hong Kong and United States. Tao Su's co-authors include Hiu Yee Kwan, Zhi‐Ling Yu, Keith E. Mostov, Anfernee Kai‐Wing Tse, Martin ter Beest, Xiu‐Qiong Fu, Huihui Cao, Brian Chi‐Yan Cheng, Mark C. Gillies and Hua Yu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Cell Biology and Hepatology.

In The Last Decade

Tao Su

121 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Su China 35 1.7k 476 443 441 418 125 3.6k
Mikio Nishizawa Japan 37 2.1k 1.2× 350 0.7× 453 1.0× 565 1.3× 565 1.4× 150 4.3k
Kang‐Beom Kwon South Korea 31 1.3k 0.8× 392 0.8× 263 0.6× 286 0.6× 270 0.6× 100 3.1k
Duan‐Fang Liao China 30 2.2k 1.3× 297 0.6× 328 0.7× 734 1.7× 349 0.8× 120 3.9k
Rajarajan A. Thandavarayan United States 38 1.7k 1.0× 287 0.6× 367 0.8× 293 0.7× 210 0.5× 136 4.2k
Sung‐Hoon Kim South Korea 38 2.3k 1.3× 411 0.9× 186 0.4× 631 1.4× 539 1.3× 157 4.3k
Dong Ju Son South Korea 36 1.8k 1.0× 725 1.5× 281 0.6× 553 1.3× 328 0.8× 119 4.0k
Lijun Xu China 30 2.0k 1.2× 572 1.2× 260 0.6× 781 1.8× 429 1.0× 126 3.4k
Hong‐Seob So South Korea 39 2.1k 1.2× 402 0.8× 211 0.5× 413 0.9× 513 1.2× 119 4.4k
Fajun Yang United States 29 2.4k 1.4× 265 0.6× 434 1.0× 609 1.4× 523 1.3× 55 4.5k
Wonchae Choe South Korea 36 2.2k 1.3× 225 0.5× 229 0.5× 486 1.1× 323 0.8× 89 3.6k

Countries citing papers authored by Tao Su

Since Specialization
Citations

This map shows the geographic impact of Tao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Su more than expected).

Fields of papers citing papers by Tao Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Su. The network helps show where Tao Su may publish in the future.

Co-authorship network of co-authors of Tao Su

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Su. A scholar is included among the top collaborators of Tao Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Su. Tao Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Cheng‐Yu, et al.. (2025). Authenticity verification and quality assessment of Taiwan Oriental Beauty oolong tea with a volatilomic strategy. Applied Food Research. 5(2). 101448–101448.
2.
Zhou, Wei, et al.. (2025). From multi-scale grids to dynamic regions: Dual-relation enhanced transformer for image captioning. Knowledge-Based Systems. 311. 113127–113127. 3 indexed citations
3.
Cui, Hui, Chunfang Yang, Lei Chen, et al.. (2024). Meroterpenoids from the marine-derived fungus Aspergillus terreus GZU-31-1 exerts anti-liver fibrosis effects by targeting the Nrf2 signaling in vitro. Phytochemistry. 219. 113983–113983. 6 indexed citations
4.
Zhang, Yong, et al.. (2023). Altered serum IGG N-glycosylation patterns are associated with disease severity in NMDAR encephalitis. Journal of the Neurological Sciences. 455. 121238–121238.
5.
Fan, Xueying, Mingjing Meng, Hui Chen, et al.. (2023). Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. Journal of Translational Medicine. 21(1). 260–260. 12 indexed citations
6.
Lu, Wen, Xiaoyue Chen, Zhen Li, et al.. (2022). A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria. Frontiers in Oncology. 12. 895834–895834. 3 indexed citations
7.
8.
Shi, Zhiqiang, Yechun Wang, Minting Chen, et al.. (2022). Discovery of a novel anti-obesity meroterpenoid agent targeted subcutaneous adipose tissue. Phytomedicine. 106. 154396–154396. 3 indexed citations
9.
Liu, Xianqiong, Junjie Hu, Xinhua Song, et al.. (2019). Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers. 11(7). 930–930. 11 indexed citations
10.
Su, Tao, Yaping Wang, Xinning Wang, et al.. (2019). The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A. Life Sciences. 241. 117169–117169. 29 indexed citations
11.
Kwan, Hiu Yee, Jiahui Wu, Tao Su, et al.. (2017). Schisandrin B regulates lipid metabolism in subcutaneous adipocytes. Scientific Reports. 7(1). 10266–10266. 17 indexed citations
12.
Su, Tao, Brian Chi‐Yan Cheng, Xiu‐Qiong Fu, et al.. (2016). Comparison of the toxicities, bioactivities and chemical profiles of raw and processed Xanthii Fructus. BMC Complementary and Alternative Medicine. 16(1). 17 indexed citations
13.
Zhang, Zheng, Liang Dong, Xue Gao, et al.. (2014). Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. Basic Research in Cardiology. 109(4). 417–417. 35 indexed citations
14.
Wang, Yabin, Chunhong Li, Kang Cheng, et al.. (2014). Activation of Liver X Receptor Improves Viability of Adipose-Derived Mesenchymal Stem Cells to Attenuate Myocardial Ischemia Injury Through TLR4/NF-κB and Keap-1/Nrf-2 Signaling Pathways. Antioxidants and Redox Signaling. 21(18). 2543–2557. 48 indexed citations
15.
Wang, Lei, Guanming Cheng, Enmin Feng, Tao Su, & Zhilong Xiu. (2014). Analysis and application of biological robustness as performance index in microbial fermentation. Applied Mathematical Modelling. 39(7). 2048–2055. 4 indexed citations
16.
Su, Tao, David M. Bryant, Frédéric Luton, et al.. (2010). A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor. Nature Cell Biology. 12(12). 1143–1153. 67 indexed citations
17.
Binaschi, Anna, Tao Su, Beatrice Paradiso, et al.. (2010). Mesoangioblast-based supplementation of neurotrophic factors for the treatment of neuronal damage. Neuroscience. 1 indexed citations
18.
Su, Tao. (2008). Obtainment and Characterization of The Evolved Enzymes From Arabidopsis thaliana Glutathione S-Transferase Zeta Class. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 1 indexed citations
19.
Yao, Yao, Yuichiro� Doki, Wei Jiang, et al.. (2000). Cloning and Characterization of DIP1, a Novel Protein That Is Related to the Id Family of Proteins. Experimental Cell Research. 257(1). 22–32. 17 indexed citations
20.
Su, Tao, et al.. (1951). Clinical evaluation of streptomycin in the treatment of bacillary dysentery in infancy and childhood. The Journal of Pediatrics. 38(5). 602–609. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikio Nishizawa Breakdown of academic impact, for papers by Kang‐Beom Kwon Breakdown of academic impact, for papers by Duan‐Fang Liao Breakdown of academic impact, for papers by Rajarajan A. Thandavarayan Breakdown of academic impact, for papers by Sung‐Hoon Kim Breakdown of academic impact, for papers by Dong Ju Son Breakdown of academic impact, for papers by Lijun Xu Breakdown of academic impact, for papers by Hong‐Seob So Breakdown of academic impact, for papers by Fajun Yang Breakdown of academic impact, for papers by Wonchae Choe
Rankless by CCL
2026